Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Dividends Paid - Common (2016 - 2025)

Medifast (MED) has disclosed Dividends Paid - Common for 10 consecutive years, with $1000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Dividends Paid - Common fell 75.0% year-over-year to $1000.0, compared with a TTM value of $195000.0 through Dec 2025, down 72.73%, and an annual FY2025 reading of $195000.0, down 72.73% over the prior year.
  • Dividends Paid - Common was $1000.0 for Q2 2025 at Medifast, down from $194000.0 in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $52.2 million in Q4 2022 and bottomed at -$29.7 million in Q4 2021.
  • Average Dividends Paid - Common over 5 years is $9.6 million, with a median of $4.1 million recorded in 2021.
  • Peak annual rise in Dividends Paid - Common hit 358.01% in 2022, while the deepest fall reached 155.34% in 2022.
  • Year by year, Dividends Paid - Common stood at -$29.7 million in 2021, then soared by 276.08% to $52.2 million in 2022, then crashed by 65.58% to $18.0 million in 2023, then plummeted by 99.99% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
  • Business Quant data shows Dividends Paid - Common for MED at $1000.0 in Q2 2025, $194000.0 in Q1 2025, and $1000.0 in Q3 2024.